Endocrinology Practice Questions

Q: A 62-year-old woman with type 2 diabetes presents with persistent hyperglycemia despite the maximum use of oral hypoglycemic agents. What is the next best step in management?

Start insulin therapy. ***Start insulin therapy*** - When **maximum doses** of oral hypoglycemic agents (OHAs) fail to achieve glycemic targets in type 2 diabetes, **insulin therapy** is generally the next recommended step. - This ensures effective glucose control and prevents long-term complications associated with **persistent hyperglycemia** [1]. *Increase oral hypoglycemics* - The patient is already on the **maximum use of oral hypoglycemic agents**, meaning further increases are unlikely to be effective and could increase side effects. - Continued escalation of OHAs beyond their maximum effective dose is not a standard or safe practice for glycemic control. *Add GLP-1 receptor agonist* - While **GLP-1 receptor agonists** can be beneficial, they are often considered *before* reaching maximal OHA therapy or in conjunction with insulin, not necessarily as the *next best step* when maximal OHAs have already failed. - In cases of **persistent hyperglycemia** despite maximal OHA use, insulin is typically the most potent and effective option for immediate and sustained glycemic control [1]. *Diet and lifestyle modification* - Diet and lifestyle modifications are **fundamental** for all diabetic patients and should always be emphasized, but in this scenario, they have likely already been implemented. - For **persistent hyperglycemia** despite maximal pharmacotherapy, lifestyle changes alone are insufficient to achieve adequate glycemic targets.

Q: A patient presents with muscle weakness and fatigue. Laboratory results show hyperkalemia. Which hormone is most likely deficient in this patient?

Aldosterone. ***Aldosterone*** - **Aldosterone deficiency** leads to impaired renal potassium excretion, resulting in **hyperkalemia** [1]. - It also causes **sodium wasting** and **hypotension**, contributing to symptoms like fatigue and weakness due to **volume depletion** [1]. *Cortisol* - **Cortisol deficiency** (e.g., in Addison's disease) often presents with **hyponatremia**, **hypotension**, and generalized weakness, but typically does not cause hyperkalemia directly [1]. - While fatigue and weakness are prominent, severe hyperkalemia is not its primary metabolic derangement related to electrolyte balance. *Insulin* - **Insulin deficiency** (e.g., in Type 1 Diabetes) primarily leads to **hyperglycemia** and metabolic acidosis [1]. - Although it can cause electrolyte imbalances like **hypokalemia** (due to intracellular shift during treatment), it does not directly cause hyperkalemia via its primary mechanism of action. *Thyroxine (T4)* - **Thyroxine deficiency** (hypothyroidism) presents with symptoms such as fatigue, weight gain, cold intolerance, and bradycardia. - It does not directly cause **hyperkalemia**; electrolyte disturbances are not a prominent feature of primary hypothyroidism.

Q: A 34-year-old woman presents with palpitations, weight loss, and heat intolerance. Physical examination reveals a diffusely enlarged thyroid. The initial laboratory test to confirm the diagnosis would be:

Thyroid-stimulating hormone (TSH) level. Thyroid-stimulating hormone (TSH) level - A **suppressed TSH level** is the most sensitive and specific initial screening test for **hyperthyroidism**, which is suggested by the patient's symptoms of palpitations, weight loss, and heat intolerance [2]. - In primary hyperthyroidism, the excessive production of thyroid hormones (T3 and T4) by the thyroid gland causes negative feedback on the pituitary, leading to a **decrease in TSH secretion** [1]. *Thyroid ultrasound* - A thyroid ultrasound provides information about the **structure** and **morphology** of the thyroid gland, such as nodularity or diffuse enlargement. - While it can confirm diffuse enlargement, it does not directly assess thyroid function or confirm the diagnosis of hyperthyroidism, which requires **biochemical testing** [1]. *Radioactive iodine uptake* - This test is used to determine the **etiology of hyperthyroidism** by measuring the thyroid gland's ability to take up iodine, helping differentiate between conditions like Graves' disease and thyroiditis [1]. - It is typically performed **after** hyperthyroidism has been biochemically confirmed (e.g., with TSH and free T4 levels) to guide treatment. *Serum thyroglobulin* - **Serum thyroglobulin** is primarily used as a tumor marker for monitoring patients with **differentiated thyroid cancer** after thyroidectomy. - Although it can be elevated in various thyroid conditions, it is not a direct measure of thyroid function and is therefore not the initial test to confirm hyperthyroidism.

Q: A 60-year-old female with hypothyroidism complains of increased lethargy and constipation. Her TSH level is elevated. What is the best management approach?

Increase levothyroxine dosage. ***Increase levothyroxine dosage*** - An **elevated TSH level** indicates that the thyroid gland is understimulated, despite the patient being on thyroid hormone replacement, implying **hypothyroidism** is not adequately controlled [1]. - Symptoms like **increased lethargy** and **constipation** are classic signs of persistent or worsening hypothyroidism, necessitating an increase in the **levothyroxine dose** [1] to achieve euthyroid status. *Reduce levothyroxine dose* - **Reducing levothyroxine** would worsen the underlying hypothyroidism, leading to a further increase in TSH and exacerbation of symptoms. - This action is appropriate only if the TSH were suppressed (low) or the patient showed signs of **hyperthyroidism** [1]. *Start liothyronine therapy* - **Liothyronine (T3)** is typically reserved for patients who do not respond adequately to levothyroxine (T4) therapy alone or in specific situations like myxedema coma. - In this case, optimizing the **levothyroxine dose** is the first-line and most effective approach; there is no indication that the patient requires T3. *Check TSH in 3 months* - While regular monitoring of TSH is crucial, simply waiting for 3 months without any intervention is inappropriate given the patient's existing **symptoms** and currently **elevated TSH**. - An immediate adjustment in the dose is needed [1], followed by re-evaluation of TSH and clinical status, typically within 6-8 weeks [1], to ensure therapeutic effectiveness.

Q: A 28-year-old male presents with muscle weakness and a history of difficulty climbing stairs. His serum potassium level is elevated. Which of the following conditions is most likely associated with hyperkalemia?

Addison's disease. **Addison's disease** - Addison's disease (primary adrenal insufficiency) leads to decreased production of **aldosterone**, a hormone responsible for sodium reabsorption and potassium excretion [2]. - The resulting **aldosterone deficiency** causes **hyperkalemia** (elevated potassium) and hyponatremia [1]. *Cushing's syndrome* - Cushing's syndrome is characterized by **excess cortisol** production, which often has mineralocorticoid effects, leading to **hypokalemia** (low potassium). - It typically presents with muscle weakness, but the serum potassium level would be low, not elevated [3]. *Primary hyperaldosteronism* - This condition involves **excessive aldosterone** production, causing increased sodium reabsorption and significant **potassium excretion** [1]. - This leads to **hypokalemia**, often with hypertension, which is the opposite of the patient's presentation [3]. *Hypothyroidism* - Severe hypothyroidism can sometimes cause mild electrolyte disturbances, but it is **not typically associated with significant hyperkalemia**. - Muscle weakness in hypothyroidism is common, but the underlying mechanism for hyperkalemia is not directly related to thyroid hormone deficiency.

Q: A 30-year-old female presents with difficulty swallowing and a sensation of a lump in her throat. Examination reveals a large, non-tender thyroid mass. What is the most appropriate next step in management?

Ultrasound of the neck. ***Ultrasound of the neck*** - An **ultrasound** is the most appropriate initial imaging study for evaluating a **thyroid mass**, as it can characterize the size, number, and features of nodules, identifying suspicious characteristics [1]. - It helps distinguish between **cystic** and **solid lesions** and guides further procedures like **fine needle aspiration (FNA)** [1]. *Thyroid function tests* - While important for assessing **thyroid hormone levels** and identifying hyper- or hypothyroidism, they do not characterize the **mass itself** or its potential for malignancy [1]. - An abnormal thyroid function test does not negate the need for anatomical evaluation of the mass. *CT scan of the neck* - A **CT scan** is typically reserved for evaluating the **extent of a large or complex thyroid mass** once malignancy is suspected, particularly for assessing tracheal compression or metastatic disease [2]. - It exposes the patient to **radiation** and is not the first-line imaging modality for initial characterization of a palpable thyroid nodule. *Fine needle aspiration biopsy* - **FNA biopsy** is crucial for obtaining tissue for **histopathological analysis** to determine if a nodule is benign or malignant [1]. - However, it should be performed **after an ultrasound** has characterized the nodule and identified features that warrant biopsy.

Q: Which treatment option would be most effective in managing a patient with hypoaldosteronism?

Fludrocortisone administration. ***Fludrocortisone administration*** - **Fludrocortisone** is a synthetic **mineralocorticoid** that mimics the action of **aldosterone**, effectively replacing the deficient hormone in hypoaldosteronism. - It helps to **retain sodium** and water, and excrete potassium, thereby correcting the electrolyte imbalances associated with the condition [1]. *Sodium restriction* - Patients with **hypoaldosteronism** already have difficulty retaining sodium due to the lack of aldosterone, leading to **hyponatremia** and fluid loss [1]. - **Restricting sodium** intake would worsen these symptoms and is contraindicated. *Potassium supplements* - **Hypoaldosteronism** typically causes **hyperkalemia** (high potassium levels) because aldosterone normally promotes potassium excretion [1]. - Therefore, **potassium supplements** would exacerbate the existing hyperkalemia and are harmful. *Increased water intake* - While patients may experience some degree of dehydration due to sodium and water loss, simply **increasing water intake** without addressing the underlying sodium deficiency can lead to **dilutional hyponatremia** [2]. - This approach does not correct the core problem of mineralocorticoid deficiency and its electrolyte imbalances.

Q: A patient on long-term corticosteroid therapy presents with symptoms of adrenal insufficiency. What is the most appropriate management strategy for this condition?

Gradual tapering of corticosteroids. **Gradual tapering of corticosteroids** * **Gradual tapering** allows the **adrenal glands** to slowly resume their natural production of **cortisol**, preventing an **adrenal crisis** [1]. * **Abrupt cessation** leads to severe **adrenal insufficiency** due to the body's dependence on exogenous corticosteroids [1]. *I*mmediate cessation of corticosteroids * **Immediate cessation** can precipitate an **adrenal crisis**, a life-threatening condition characterized by **hypotension**, **shock**, and **electrolyte imbalance**. * This approach does not allow the **hypothalamic-pituitary-adrenal (HPA) axis** to recover, leading to severe cortisol deficiency [1]. *Switch to a different corticosteroid * Switching to a different corticosteroid would not address the underlying issue of **adrenal suppression** caused by long-term exogenous corticosteroid use. * The goal is to restore endogenous **cortisol production**, which requires reducing the overall corticosteroid load. *Addition of a mineralocorticoid * **Mineralocorticoid** replacement (e.g., fludrocortisone) is primarily indicated for **primary adrenal insufficiency** (e.g., Addison's disease), where **aldosterone production** is impaired. * In **secondary adrenal insufficiency** from long-term corticosteroid use, **aldosterone secretion** is usually preserved, as it is mainly regulated by the **renin-angiotensin system** [2].

Q: A patient presents with signs of Cushing's syndrome. Which hormone is primarily responsible for this condition?

Cortisol. ***Cortisol*** - **Cushing's syndrome** is primarily caused by prolonged exposure to **high levels of cortisol**, leading to a characteristic set of signs and symptoms [1]. - **Cortisol** is a glucocorticoid hormone involved in stress response, metabolism, and immune function, and its excess disrupts these processes [1]. *Aldosterone* - **Aldosterone** is a mineralocorticoid hormone involved in **sodium and potassium balance**, and its excess leads to conditions like Conn's syndrome (**hyperaldosteronism**), not Cushing's syndrome [2]. - Symptoms of **hyperaldosteronism** include hypertension and hypokalemia, which differ from the classic features of Cushing's syndrome. *Thyroxine* - **Thyroxine** is a thyroid hormone that regulates metabolism; its excess causes **hyperthyroidism**, characterized by weight loss, tachycardia, and heat intolerance. - **Hyperthyroidism** symptoms are distinct from the weight gain, central obesity, and hyperglycemia seen in **Cushing's syndrome**. *Insulin* - **Insulin** is a pancreatic hormone responsible for glucose uptake by cells; its deficiency or resistance causes **diabetes mellitus**. - While **hyperglycemia** can occur in Cushing's syndrome due to cortisol's effects, **insulin itself is not the primary hormone** responsible for the syndrome's overall pathogenesis.

Question 1

A 62-year-old woman with type 2 diabetes presents with persistent hyperglycemia despite the maximum use of oral hypoglycemic agents. What is the next best step in management?

Accepted Answer

Start insulin therapy

Answer

Increase oral hypoglycemics

Answer

Add GLP-1 receptor agonist

Answer

Diet and lifestyle modification

Question 2

A patient presents with muscle weakness and fatigue. Laboratory results show hyperkalemia. Which hormone is most likely deficient in this patient?

Accepted Answer

Aldosterone

Answer

Cortisol

Answer

Insulin

Answer

Thyroxine (T4)

Question 3

A patient with a history of type 2 diabetes and peripheral neuropathy presents with a red, swollen left foot, with no open wounds present. What is the most appropriate treatment?

Accepted Answer

Immediate immobilization and non-weight bearing with urgent imaging

Answer

Blood sugar optimization and routine follow-up

Answer

Oral antibiotics and close monitoring

Answer

Topical anti-inflammatory cream and elevation

Question 4

A 34-year-old woman presents with palpitations, weight loss, and heat intolerance. Physical examination reveals a diffusely enlarged thyroid. The initial laboratory test to confirm the diagnosis would be:

Accepted Answer

Thyroid-stimulating hormone (TSH) level

Answer

Thyroid ultrasound

Answer

Radioactive iodine uptake

Answer

Serum thyroglobulin

Question 5

A 60-year-old female with hypothyroidism complains of increased lethargy and constipation. Her TSH level is elevated. What is the best management approach?

Accepted Answer

Increase levothyroxine dosage

Answer

Reduce levothyroxine dose

Answer

Start liothyronine therapy

Answer

Check TSH in 3 months

Question 6

A 28-year-old male presents with muscle weakness and a history of difficulty climbing stairs. His serum potassium level is elevated. Which of the following conditions is most likely associated with hyperkalemia?

Accepted Answer

Addison's disease

Answer

Hypothyroidism

Answer

Primary hyperaldosteronism

Answer

Cushing's syndrome

Question 7

A 30-year-old female presents with difficulty swallowing and a sensation of a lump in her throat. Examination reveals a large, non-tender thyroid mass. What is the most appropriate next step in management?

Accepted Answer

Ultrasound of the neck

Answer

Thyroid function tests

Answer

CT scan of the neck

Answer

Fine needle aspiration biopsy

Question 8

Which treatment option would be most effective in managing a patient with hypoaldosteronism?

Accepted Answer

Fludrocortisone administration

Answer

Sodium restriction

Answer

Potassium supplements

Answer

Increased water intake

Question 9

A patient on long-term corticosteroid therapy presents with symptoms of adrenal insufficiency. What is the most appropriate management strategy for this condition?

Accepted Answer

Gradual tapering of corticosteroids

Answer

Immediate cessation of corticosteroids

Answer

Switch to a different corticosteroid

Answer

Addition of a mineralocorticoid

Question 10

A patient presents with signs of Cushing's syndrome. Which hormone is primarily responsible for this condition?

Accepted Answer

Cortisol

Answer

Aldosterone

Answer

Thyroxine

Answer

Insulin

Endocrinology — MCQs

Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?